Condition: Symptomatic Functional MR 3 or Greater · Sponsor: Valcare Medical Ltd.
Valcare Medical AMEND Trans-Septal System is a mitral valve repair annuloplasty ring implanted in a trans-catheter method intended for correction of mitral regurgitation. It is designed to be used as standalone therapy or in combination with other repair treatments.
This description comes directly from the study's public registry record.
Anat Eitan, VP RA & Clinical · +972546280106 · aeitan@valcaremedical.com
Madhuri Bhat · 408-230-2442 · mbhat@valcaremedical.com
Always discuss trial participation with your own doctor first.
| Banner University Medical Center - Phoenix | Phoenix, Arizona, United States | Recruiting |
| Scripps Health | La Jolla, California, United States | Not Yet Recruiting |
| Piedmont Healthcare | Atlanta, Georgia, United States | Not Yet Recruiting |
| Ascension St. Vincent | Indianapolis, Indiana, United States | Recruiting |
| Columbia University Medical Center (CUMC) | New York, New York, United States | Recruiting |
| Montefiore Medical Center | The Bronx, New York, United States | Not Yet Recruiting |
| Oregon Health & Science University (OHSU) | Portland, Oregon, United States | Recruiting |
| Saint Thomas Research Institute | Nashville, Tennessee, United States | Not Yet Recruiting |
| University of Texas Health Science Center (UTH) | Houston, Texas, United States | Recruiting |
| Methodist Hospital HCA | San Antonio, Texas, United States | Recruiting |
| Intermountain Health | Murray, Utah, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06951672